Deutsch English Français

Contact

EP1164200

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1164200

EP1164200 - Method and device for drug-drug interaction testing sample preparation [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 01.04.2005 Database last updated on 13.11.2024
Most recent event Tooltip	01.04.2005	Application deemed to be withdrawn	published on 18.05.2005 [2005/20]
Applicant(s)	For all designated states Pfizer Products Inc. Eastern Point Road Groton, CT 06340 / US
	[N/P]
Former [2001/51]	For all designated states Pfizer Products Inc. Eastern Point Road Groton, Connecticut 06340 / US
Inventor(s)	01 / Ekins, Sean 925 North Alabama Street Indianapolis, Indiana 46202 / US
	02 / Kelly, Kevin George, Pfizer Global R. & D. Eastern Point Road Groton, Connecticut 06340 / US
	03 / Johnson, Diane Lynn, Pfizer Global R. & D. Eastern Point Road Groton, Connecticut 06340 / US
	[2004/20]
Former [2001/51]	01 / Ekins, Sean 925 North Alabama Street Indianapolis, Indiana 46202 / US
	02 / Kelly, Kevin George, Pfizer Global Research and Development, Eastern Point Road Groton, Connecticut 06340 / US
	03 / Johnson, Diane Lynn, Pfizer Global Research and Development, Eastern Point Road Groton, Connecticut 06340 / US
Representative(s)	Simpson, Alison Elizabeth Fraser, et al Urquhart-Dykes & Lord LLP The Podium 1 Eversholt Street London NW1 2DN / GB
	[N/P]
Former [2001/51]	Simpson, Alison Elizabeth Fraser, et al Urquhart-Dykes & Lord, 30 Welbeck Street London W1G 8ER / GB
Application number, filing date	01304627.1	25.05.2001
	[2001/51]
Priority number, date	US20000208213P	31.05.2000 Original published format: US 208213 P
	[2001/51]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP1164200
	Date:	19.12.2001
	Language:	EN
	[2001/51]
	Type:	A3 Search report
	No.:	EP1164200
	Date:	18.02.2004
	[2004/08]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	05.01.2004
Classification	IPC:	C12Q1/26, G01N33/50, G01N35/00, G01N35/02	[2004/06]
	CPC:	G01N33/5076 (EP,US); C12Q1/26 (EP,US); G01N35/028 (EP,US); B01L3/50255 (EP,US); G01N1/4077 (EP,US); G01N2035/00356 (EP,US); (+) G01N2035/00445 (EP,US); G01N2035/0422 (EP,US); G01N35/1074 (EP,US) (-)
	Former IPC [2001/51]	C12Q1/26, G01N33/50
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2001/51]
Title	German:	Methode und Vorrichtung für die Präparation von Testproben zur Messung von Arzneimittel-Arzneimittel Wechselwirkungen	[2001/51]
	English:	Method and device for drug-drug interaction testing sample preparation	[2001/51]
	French:	Méthode et dispositif pour la préparation d'échantillons de test d'interactions médicament-médicament	[2001/51]
Examination procedure	08.06.2001	Examination requested [2001/51]
	30.06.2004	Despatch of a communication from the examining division (Time limit: M04)
	11.11.2004	Application deemed to be withdrawn, date of legal effect [2005/20]
	17.12.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2005/20]
Fees paid	Renewal fee
	21.03.2003	Renewal fee patent year 03
	26.03.2004	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]EP0289789 (JAPAN TECTRON INSTR CORP [JP]) [Y] 2 * abstract *;
		[X]WO9116675 (APPLIED BIOSYSTEMS [US]) [X] 5 * abstract *;
		[Y]EP0645459 (COOK DORN C [US], et al) [Y] 1,3,4 * abstract *;
		[Y]US5443791 (CATHCART G RICHARD [US], et al) [Y] 2 * abstract *;
		[A]US5939530 (GELBOIN HARRY V [US], et al) [A] 1,3,4 * column 3, line 55 - column 5, line 26; example 5 *;
		[A]WO0004864 (US HEALTH [US], et al) [A] 1,3,4 * page 15, line 22 - page 17, line 15 *;
		[T]EP1150120 (PFIZER PROD INC [US]) [T] 1,3,4* the whole document *;
		[T]WO0204660 (AMERICAN HOME PROD [US], et al) [T] 1,3,4 * the whole document *;
		[X] - MILLER L S ET AL, "A robotic immunoassay system for detergent enzymes", CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS: LABORATORY INFORMATION MANAGEMENT 1994 NETHERLANDS, (1994), vol. 26, no. 2, ISSN 0925-5281, pages 79 - 87, XP000476919 [X] 5 * the whole document *
		[Y] - MOODY G C ET AL, "FULLY AUTOMATED ANALYSIS OF ACTIVITIES CATALYSED BY THE MAJOR HUMAN LIVER CYTOCHROME P450 (CYP) ENZYMES: ASSESSMENT OF HUMAN CYP INHIBITION POTENTIAL", XENOBIOTICA, TAYLOR AND FRANCIS, LONDON,, GB, (199901), vol. 29, no. 1, ISSN 0049-8254, pages 53 - 75, XP001022904 [Y] 1,3,4 * page 56, paragraph 2 - page 57, paragraph 2; figure 1; table 1 * DOI: http://dx.doi.org/10.1080/004982599238812
		[Y] - YIN H ET AL, "Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: Application in CYP inhibition evaluation.", XENOBIOTICA., (200002), vol. 30, no. 2, ISSN 0049-8254, pages 141 - 154, XP009004649 [Y] 1,3,4 * page 142, paragraph 2 - page 144, paragraph 5 * DOI: http://dx.doi.org/10.1080/004982500237749

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p